Screener
BioMarin Pharmaceuticals BMRN Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
| ASSETS | June 30, 2026 / (unaudited) | December 31, 2025 ⁽¹⁾ |
|---|---|---|
| Short-term investments | — | 248,930 |
| Accounts receivable, net | 1,061,047 | 908,214 |
| Inventory | 1,782,524 | 1,298,883 |
| Other current assets | 254,047 | 185,784 |
| Total current assets | 3,971,623 | 3,953,490 |
| Noncurrent assets: | ||
| Long-term investments | — | 492,242 |
| Property, plant and equipment, net | 989,994 | 952,508 |
Item 1. Financial Statements
FAQ
- What is BioMarin Pharmaceuticals's prepaid & other current?
- BioMarin Pharmaceuticals (BMRN) reported prepaid & other current of $254.05M in Q2 2026.
- How has BioMarin Pharmaceuticals's prepaid & other current changed year-over-year?
- BioMarin Pharmaceuticals's prepaid & other current increased by 43.4% year-over-year, from $177.18M to $254.05M.
- What is the long-term trend for BioMarin Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's prepaid & other current has grown at a 7.4% compound annual growth rate (CAGR), from $129.93M to $185.78M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about BioMarin Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude